gadolinium chloride has been researched along with Diabetes Mellitus, Type 2 in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, F; Chen, Y; Dong, M; Li, Z; Wang, N; Wang, Q | 1 |
1 other study(ies) available for gadolinium chloride and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
GdCl3 reduces hyperglycaemia through Akt/FoxO1-induced suppression of hepatic gluconeogenesis in Type 2 diabetic mice.
Topics: Animals; Blood Glucose; Cells, Cultured; Diabetes Mellitus, Type 2; Diet, High-Fat; Forkhead Box Protein O1; Forkhead Transcription Factors; Gadolinium; Gluconeogenesis; Glucose; Glucose-6-Phosphatase; Hyperglycemia; Liver; Male; Mice; Mice, Inbred C57BL; Phosphorylation; Proto-Oncogene Proteins c-akt | 2014 |